Important Notice Regarding Inveltys

Posted in Latest News on February 11, 2019.

During the February 8, 2019 Board of Optometry meeting, the board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents.

Important note: At this time, Inveltys cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and Inveltys may be prescribed by certified optometrists at that time.



More Latest News

Important Notice Regarding Oxervate
January 24, 2020

The Board of Optometry has approved Oxervate (Cenegermin-bkbj) 0.002% for addition to Rule 64B13-18.002. Continue reading


Electronic Prescribing Requirements
January 2, 2020

Click here for the new requirements requiring prescribers to generate and transmit all prescriptions electronically Continue reading